Jiangxi Rimag (HKG:2522) said it expects its H1 profit to rise by up to 1,550% year over year, according to a Hong Kong bourse filing Monday.

Shares of the medical imaging company jumped 15% in recent trade.

The company expects to report 14.5 million yuan to 16.5 million yuan in profit for the six months ended June 30, an increase of 1,350% to 1,550% from the 1 million yuan reported a year prior.

Revenue for the period is expected to rise 9% to 16% to 450 million yuan to 480 million yuan, the firm said.

The company's financial results are due by the end of August.